Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toos Daemen

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Oncoimmunology|May 8, 2015
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradicationOana Draghiciu, Hans W Nijman, Baukje Nynke Hoogeboom, et al.
Current Pharmaceutical Design|May 18, 2012
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigenRenee Vermeij, Ninke Leffers, Cornelis J Melief, et al.
Oncoimmunology|October 10, 2015
A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor developmentOana Draghiciu, Annemarie Boerma, Baukje Nynke Hoogeboom, et al.
Immunotherapy|July 20, 2010
Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious diseaseNinke Leffers, Toos Daemen, Ate G J van der Zee, et al.
Vaccine|February 1, 2003
Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7Toos Daemen, Annelies Riezebos-Brilman, Laura Bungener, et al.
Journal of Liposome Research|February 27, 2003
Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigensLaura Bungener, Jacqueline Idema, Wouter ter Veer, et al.
Molecular Therapy Oncolytics|November 11, 2021
A systematic analysis on the clinical safety and efficacy of onco-virotherapyDarshak K Bhatt, Lieske Wekema, Luciana Rodrigues Carvalho Barros, et al.
Vaccine|May 16, 2002
Virosome-mediated delivery of protein antigens to dendritic cellsLaura Bungener, Karine Serre, Liesbeth Bijl, et al.
Advanced Drug Delivery Reviews|November 25, 2004
Virosomes for antigen and DNA deliveryToos Daemen, Arjan de Mare, Laura Bungener, et al.
Therapeutic Advances in Vaccines and Immunotherapy|October 18, 2019
Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?Georgia Koutsoumpli, Peng Peng Ip, Ilona Schepel, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Oncoimmunology|May 8, 2015
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradicationOana Draghiciu, Hans W Nijman, Baukje Nynke Hoogeboom, et al.
Current Pharmaceutical Design|May 18, 2012
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigenRenee Vermeij, Ninke Leffers, Cornelis J Melief, et al.
Oncoimmunology|October 10, 2015
A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor developmentOana Draghiciu, Annemarie Boerma, Baukje Nynke Hoogeboom, et al.
Immunotherapy|July 20, 2010
Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious diseaseNinke Leffers, Toos Daemen, Ate G J van der Zee, et al.
Vaccine|February 1, 2003
Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7Toos Daemen, Annelies Riezebos-Brilman, Laura Bungener, et al.
Journal of Liposome Research|February 27, 2003
Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigensLaura Bungener, Jacqueline Idema, Wouter ter Veer, et al.
Molecular Therapy Oncolytics|November 11, 2021
A systematic analysis on the clinical safety and efficacy of onco-virotherapyDarshak K Bhatt, Lieske Wekema, Luciana Rodrigues Carvalho Barros, et al.
Vaccine|May 16, 2002
Virosome-mediated delivery of protein antigens to dendritic cellsLaura Bungener, Karine Serre, Liesbeth Bijl, et al.
Advanced Drug Delivery Reviews|November 25, 2004
Virosomes for antigen and DNA deliveryToos Daemen, Arjan de Mare, Laura Bungener, et al.
Therapeutic Advances in Vaccines and Immunotherapy|October 18, 2019
Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?Georgia Koutsoumpli, Peng Peng Ip, Ilona Schepel, et al.
Pageof 9